189 related articles for article (PubMed ID: 29185604)
1. Glycemic control and adipokines after periodontal therapy in patients with Type 2 diabetes and chronic periodontitis.
Wang S; Liu J; Zhang J; Lin J; Yang S; Yao J; Du M
Braz Oral Res; 2017 Nov; 31():e90. PubMed ID: 29185604
[TBL] [Abstract][Full Text] [Related]
2. Adipokines and inflammatory mediators after initial periodontal treatment in patients with type 2 diabetes and chronic periodontitis.
Kardeşler L; Buduneli N; Cetinkalp S; Kinane DF
J Periodontol; 2010 Jan; 81(1):24-33. PubMed ID: 20059414
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory cytokines, adiponectin, insulin resistance and metabolic control after periodontal intervention in patients with type 2 diabetes and chronic periodontitis.
Sun WL; Chen LL; Zhang SZ; Wu YM; Ren YZ; Qin GM
Intern Med; 2011; 50(15):1569-74. PubMed ID: 21804283
[TBL] [Abstract][Full Text] [Related]
4. [Effect of non-surgical periodontal therapy on glycemic control and the level of serum IL-6 in type 2 diabetic patients with chronic periodontitis].
Wei JJ; Chang CR; Pan YP; Yu N; Zhao H
Zhonghua Kou Qiang Yi Xue Za Zhi; 2011 Feb; 46(2):70-4. PubMed ID: 21426773
[TBL] [Abstract][Full Text] [Related]
5. Effect of periodontal treatment on metabolic control, systemic inflammation and cytokines in patients with type 2 diabetes.
Correa FO; Gonçalves D; Figueredo CM; Bastos AS; Gustafsson A; Orrico SR
J Clin Periodontol; 2010 Jan; 37(1):53-8. PubMed ID: 19968741
[TBL] [Abstract][Full Text] [Related]
6. Periodontal treatment with topical antibiotics improves glycemic control in association with elevated serum adiponectin in patients with type 2 diabetes mellitus.
Bharti P; Katagiri S; Nitta H; Nagasawa T; Kobayashi H; Takeuchi Y; Izumiyama H; Uchimura I; Inoue S; Izumi Y
Obes Res Clin Pract; 2013; 7(2):e129-e138. PubMed ID: 24331774
[TBL] [Abstract][Full Text] [Related]
7. Local and serum levels of adipokines in patients with obesity after periodontal therapy: one-year follow-up.
Gonçalves TE; Zimmermann GS; Figueiredo LC; Souza Mde C; da Cruz DF; Bastos MF; da Silva HD; Duarte PM
J Clin Periodontol; 2015 May; 42(5):431-9. PubMed ID: 25858047
[TBL] [Abstract][Full Text] [Related]
8. Changes of adiponectin and inflammatory cytokines after periodontal intervention in type 2 diabetes patients with periodontitis.
Sun WL; Chen LL; Zhang SZ; Ren YZ; Qin GM
Arch Oral Biol; 2010 Dec; 55(12):970-4. PubMed ID: 20889139
[TBL] [Abstract][Full Text] [Related]
9. Relationships among interleukin-6, tumor necrosis factor-α, adipokines, vitamin D, and chronic periodontitis.
Teles FR; Teles RP; Martin L; Socransky SS; Haffajee AD
J Periodontol; 2012 Sep; 83(9):1183-91. PubMed ID: 22181684
[TBL] [Abstract][Full Text] [Related]
10. Effect of non-surgical periodontal treatment on visfatin concentrations in serum and gingival crevicular fluid of patients with chronic periodontitis and type 2 diabetes mellitus.
Wu Y; Chen L; Wei B; Luo K; Yan F
J Periodontol; 2015 Jun; 86(6):795-800. PubMed ID: 25786566
[TBL] [Abstract][Full Text] [Related]
11. Short term effects of periodontal therapy on inflammatory markers in patients with type-2 diabetes.
Kara G; Cifcibasi E; Karsidag K; Cintan S
Saudi Med J; 2015 Apr; 36(4):469-76. PubMed ID: 25828285
[TBL] [Abstract][Full Text] [Related]
12. Influence of type 2 diabetes on local production of inflammatory molecules in adults with and without chronic periodontitis: a cross-sectional study.
Mohamed HG; Idris SB; Ahmed MF; Åstrøm AN; Mustafa K; Ibrahim SO; Mustafa M
BMC Oral Health; 2015 Jul; 15():86. PubMed ID: 26211001
[TBL] [Abstract][Full Text] [Related]
13. Supragingival biofilm control and systemic inflammation in patients with type 2 diabetes mellitus.
Artese HP; Longo PL; Gomes GH; Mayer MP; Romito GA
Braz Oral Res; 2015; 29():. PubMed ID: 26039911
[TBL] [Abstract][Full Text] [Related]
14. The effects of melatonin supplementation in adjunct with non-surgical periodontal therapy on periodontal status, serum melatonin and inflammatory markers in type 2 diabetes mellitus patients with chronic periodontitis: a double-blind, placebo-controlled trial.
Bazyar H; Gholinezhad H; Moradi L; Salehi P; Abadi F; Ravanbakhsh M; Zare Javid A
Inflammopharmacology; 2019 Feb; 27(1):67-76. PubMed ID: 30328031
[TBL] [Abstract][Full Text] [Related]
15. The effect of nonsurgical periodontal therapy on hemoglobin A1c levels in persons with type 2 diabetes and chronic periodontitis: a randomized clinical trial.
Engebretson SP; Hyman LG; Michalowicz BS; Schoenfeld ER; Gelato MC; Hou W; Seaquist ER; Reddy MS; Lewis CE; Oates TW; Tripathy D; Katancik JA; Orlander PR; Paquette DW; Hanson NQ; Tsai MY
JAMA; 2013 Dec; 310(23):2523-32. PubMed ID: 24346989
[TBL] [Abstract][Full Text] [Related]
16. Serum immunoglobulin levels in type 2 diabetes patients with chronic periodontitis.
Awartani F
J Contemp Dent Pract; 2010 May; 11(3):001-8. PubMed ID: 20461318
[TBL] [Abstract][Full Text] [Related]
17. The effect of periodontal therapy on serum TNF-alpha and HbA1c levels in type 2 diabetic patients.
Dağ A; Firat ET; Arikan S; Kadiroğlu AK; Kaplan A
Aust Dent J; 2009 Mar; 54(1):17-22. PubMed ID: 19228128
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of initial periodontal therapy and its correlation with white blood cell level in periodontitis patients with or without diabetes mellitus].
Xu XR; Huo PC; He L; Meng HX; Zhu YX; Jin DS
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 54(1):48-53. PubMed ID: 35165467
[TBL] [Abstract][Full Text] [Related]
19. Association of periodontal parameters with metabolic level and systemic inflammatory markers in patients with type 2 diabetes.
Chen L; Wei B; Li J; Liu F; Xuan D; Xie B; Zhang J
J Periodontol; 2010 Mar; 81(3):364-71. PubMed ID: 20192862
[TBL] [Abstract][Full Text] [Related]
20. Routine prophylaxes every 3 months improves chronic periodontitis status in type 2 diabetes.
López NJ; Quintero A; Casanova PA; Martínez B
J Periodontol; 2014 Jul; 85(7):e232-40. PubMed ID: 24354651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
